188 related articles for article (PubMed ID: 31919321)
1. [Research progress in NADPH oxidase family in cardiovascular diseases].
Cao J; Liu Z; Xu Q; Shi R; Zhang G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Nov; 44(11):1258-1267. PubMed ID: 31919321
[TBL] [Abstract][Full Text] [Related]
2. NADPH oxidases and vascular remodeling in cardiovascular diseases.
García-Redondo AB; Aguado A; Briones AM; Salaices M
Pharmacol Res; 2016 Dec; 114():110-120. PubMed ID: 27773825
[TBL] [Abstract][Full Text] [Related]
3. NADPH oxidases: key modulators in aging and age-related cardiovascular diseases?
Sahoo S; Meijles DN; Pagano PJ
Clin Sci (Lond); 2016 Mar; 130(5):317-35. PubMed ID: 26814203
[TBL] [Abstract][Full Text] [Related]
4. NADPH Oxidase Inhibition: Preclinical and Clinical Studies in Diabetic Complications.
Urner S; Ho F; Jha JC; Ziegler D; Jandeleit-Dahm K
Antioxid Redox Signal; 2020 Aug; 33(6):415-434. PubMed ID: 32008354
[No Abstract] [Full Text] [Related]
5. The Nox family of NADPH oxidases: friend or foe of the vascular system?
Takac I; Schröder K; Brandes RP
Curr Hypertens Rep; 2012 Feb; 14(1):70-8. PubMed ID: 22071588
[TBL] [Abstract][Full Text] [Related]
6. The role of NADPH oxidase in vascular disease--hypertension, atherosclerosis & stroke.
Gray SP; Jandeleit-Dahm KA
Curr Pharm Des; 2015; 21(41):5933-44. PubMed ID: 26510435
[TBL] [Abstract][Full Text] [Related]
7. NADPH oxidase-derived reactive oxygen species: involvement in vascular physiology and pathology.
Manea A
Cell Tissue Res; 2010 Dec; 342(3):325-39. PubMed ID: 21052718
[TBL] [Abstract][Full Text] [Related]
8. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
Paravicini TM; Touyz RM
Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
[TBL] [Abstract][Full Text] [Related]
9. NADPH oxidases in cardiovascular health and disease.
Cave AC; Brewer AC; Narayanapanicker A; Ray R; Grieve DJ; Walker S; Shah AM
Antioxid Redox Signal; 2006; 8(5-6):691-728. PubMed ID: 16771662
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species and vascular biology: implications in human hypertension.
Touyz RM; Briones AM
Hypertens Res; 2011 Jan; 34(1):5-14. PubMed ID: 20981034
[TBL] [Abstract][Full Text] [Related]
11. A Mini-Review of the NADPH oxidases in Vascular Dementia: Correlation with NOXs and Risk Factors for VaD.
Choi DH; Lee J
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165383
[TBL] [Abstract][Full Text] [Related]
12. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases.
Sedeek M; Hébert RL; Kennedy CR; Burns KD; Touyz RM
Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):122-7. PubMed ID: 19430333
[TBL] [Abstract][Full Text] [Related]
13. NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets.
Zhang Y; Murugesan P; Huang K; Cai H
Nat Rev Cardiol; 2020 Mar; 17(3):170-194. PubMed ID: 31591535
[TBL] [Abstract][Full Text] [Related]
14. The role of the methoxyphenol apocynin, a vascular NADPH oxidase inhibitor, as a chemopreventative agent in the potential treatment of cardiovascular diseases.
Yu J; Weïwer M; Linhardt RJ; Dordick JS
Curr Vasc Pharmacol; 2008 Jul; 6(3):204-17. PubMed ID: 18673160
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms for suppressing NADPH oxidase in the vascular wall.
Dusting GJ; Selemidis S; Jiang F
Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():97-103. PubMed ID: 15962105
[TBL] [Abstract][Full Text] [Related]
16. Opportunity nox: the future of NADPH oxidases as therapeutic targets in cardiovascular disease.
Streeter J; Thiel W; Brieger K; Miller FJ
Cardiovasc Ther; 2013 Jun; 31(3):125-37. PubMed ID: 22280098
[TBL] [Abstract][Full Text] [Related]
17. The natural phenolic compounds as modulators of NADPH oxidases in hypertension.
Yousefian M; Shakour N; Hosseinzadeh H; Hayes AW; Hadizadeh F; Karimi G
Phytomedicine; 2019 Mar; 55():200-213. PubMed ID: 30668430
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
Montezano AC; Touyz RM
Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
[TBL] [Abstract][Full Text] [Related]
19. Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system.
Lassègue B; San Martín A; Griendling KK
Circ Res; 2012 May; 110(10):1364-90. PubMed ID: 22581922
[TBL] [Abstract][Full Text] [Related]
20. Composition and functions of vascular nicotinamide adenine dinucleotide phosphate oxidases.
Brandes RP; Schröder K
Trends Cardiovasc Med; 2008 Jan; 18(1):15-9. PubMed ID: 18206804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
